Sorbonne Université – ‘From Fundamental Molecular Biosciences to Biotherapies’



From Fundamental Molecular Biosciences to Biotherapies

Diploma level/grade delivered :

Master 1 / Master 2

Applications accepted from students having completed : 
Bachelor’s degree / Master 1 / Master 2 

The field of biotherapy regroups the therapeutics based on the use of molecules designed from a living organism. Biotherapies comprise cell and tissue therapy, gene therapy and therapies using human molecules synthesized by eukaryotic cells or bacteria, as antibodies and bioactive proteins. This domain has considerably evolved during the recent years thanks to the research progress in vectorology, stem cells, biomaterials, omics and computational biology, which have transformed the practices of research laboratories in fundamental biology and biotherapy and allowed numerous clinical trials to emerge. The societal and ethical impact of these new features is huge and the area of biotherapy will need experts in the next future. Future researchers in this field require a strong education in the molecular basis of the physiopathological processes to develop new biotherapy strategies. The aim of the international master « From fundamental molecular biosciences to biotherapies » is to offer an integrated state-of-the-art training in fundamental molecular biosciences applied to biotherapies through a multidisciplinary approach that conforms to the trends and development within the field. The program consists of four semesters, covering a total of 120 ECTS and offers students the opportunity, in addition to a high quality education in Molecular Biosciences delivered at Sorbonne Université (Paris), to choose a specialisation option among the different fields of biotherapies in different partners universities: • Cancer biology: Heidelberg university (Germany) • Immunology and biotherapies: Prague Charles university (Czech republic), Sao Paulo university (Brasil) • Stem cell, Development and Evolution: Lisbon university (Portugal), Heidelberg university (Germany) • Bioinformatics for health sciences: Heidelberg university (Germany) and Barcelona Pompeu Fabra university (Spain). • Fundamental molecular biosciences in biotherapies: Sorbonne-Université (Paris) The program’s objective is to attract motivated students to a fully integrated Master course that combines the best elements of existing courses by the consortium members. Graduates will emerge with critical understanding of basic and applied scientific knowledge and excellent professional and personal skills. The specializations allow students to obtain original multiple high qualifications in complementary disciplines and generate career opportunities in academic research, pharmaceutical industry, biomedical research with an emphasis on molecular aspects of biotherapies.
Address Website
4, Place Jussieu, Paris